Tantalus gearing up for medical cannabis crops
May 29, 2017, Vancouver – B.C.-based medical cannabis producer Tantalus Labs has received its licence to cultivate medical marijuana, issued by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
The acquisition of this licence marks a significant landmark for the company. They will begin cultivation in their novel high-efficiency facility SunLab, in the coming weeks.
SunLab’s purpose-built, specialized greenhouses utilize sunlight for the plant’s primary photosynthetic input, rather than artificial lighting. This reduces electricity demand by up to 90 per cent, compared to historical illicit-market practices. Tantalus Labs is committed to developing environmentally sustainable best practices for cannabis cultivation.
‘A CRITICAL MILESTONE’
“This is a critical milestone for our team at Tantalus Labs and the future of the Sungrown cannabis movement, both in Canada and around the world,” says Dan Sutton, managing director of Tantalus Labs.
“After five years of dedication to building a brighter future for cannabis, our team is thrilled to begin production.”
Tantalus Labs will be embarking on a round of fundraising activity in the coming weeks in collaboration with their banking partner, Capital West Partners, a leading Financial Services firm located in Vancouver.